vs
MIMEDX GROUP, INC.（MDXG）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
MIMEDX GROUP, INC.的季度营收约是RESOURCES CONNECTION, INC.的1.0倍（$118.1M vs $117.7M），MIMEDX GROUP, INC.净利率更高（12.9% vs -10.8%，领先23.6%），MIMEDX GROUP, INC.同比增速更快（27.1% vs -19.2%），过去两年MIMEDX GROUP, INC.的营收复合增速更高（18.1% vs -11.8%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
MDXG vs RGP — 直观对比
营收规模更大
MDXG
是对方的1.0倍
$117.7M
营收增速更快
MDXG
高出46.3%
-19.2%
净利率更高
MDXG
高出23.6%
-10.8%
两年增速更快
MDXG
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $117.7M |
| 净利润 | $15.2M | $-12.7M |
| 毛利率 | 83.9% | 37.1% |
| 营业利润率 | 17.8% | -10.3% |
| 净利率 | 12.9% | -10.8% |
| 营收同比 | 27.1% | -19.2% |
| 净利润同比 | 104.2% | 81.6% |
| 每股收益（稀释后） | $0.10 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRGP
| Q4 25 | $118.1M | $117.7M | ||
| Q3 25 | $113.7M | $120.2M | ||
| Q2 25 | $98.6M | $139.3M | ||
| Q1 25 | $88.2M | $129.4M | ||
| Q4 24 | $92.9M | $145.6M | ||
| Q3 24 | $84.1M | $136.9M | ||
| Q2 24 | $87.2M | $148.2M | ||
| Q1 24 | $84.7M | $151.3M |
净利润MDXGRGP
| Q4 25 | $15.2M | $-12.7M | ||
| Q3 25 | $16.7M | $-2.4M | ||
| Q2 25 | $9.6M | $-73.3M | ||
| Q1 25 | $7.0M | $-44.1M | ||
| Q4 24 | $7.4M | $-68.7M | ||
| Q3 24 | $8.1M | $-5.7M | ||
| Q2 24 | $17.6M | $10.5M | ||
| Q1 24 | $9.3M | $2.5M |
毛利率MDXGRGP
| Q4 25 | 83.9% | 37.1% | ||
| Q3 25 | 83.5% | 39.5% | ||
| Q2 25 | 81.1% | 40.2% | ||
| Q1 25 | 81.2% | 35.1% | ||
| Q4 24 | 81.8% | 38.5% | ||
| Q3 24 | 81.8% | 36.5% | ||
| Q2 24 | 83.0% | 40.2% | ||
| Q1 24 | 84.7% | 37.0% |
营业利润率MDXGRGP
| Q4 25 | 17.8% | -10.3% | ||
| Q3 25 | 19.5% | -1.7% | ||
| Q2 25 | 12.5% | -47.0% | ||
| Q1 25 | 9.4% | -38.4% | ||
| Q4 24 | 11.9% | -52.7% | ||
| Q3 24 | 13.3% | -3.5% | ||
| Q2 24 | 26.9% | 7.6% | ||
| Q1 24 | 15.6% | 2.8% |
净利率MDXGRGP
| Q4 25 | 12.9% | -10.8% | ||
| Q3 25 | 14.7% | -2.0% | ||
| Q2 25 | 9.8% | -52.6% | ||
| Q1 25 | 8.0% | -34.0% | ||
| Q4 24 | 8.0% | -47.2% | ||
| Q3 24 | 9.6% | -4.2% | ||
| Q2 24 | 20.2% | 7.1% | ||
| Q1 24 | 10.9% | 1.7% |
每股收益（稀释后）MDXGRGP
| Q4 25 | $0.10 | $-0.38 | ||
| Q3 25 | $0.11 | $-0.07 | ||
| Q2 25 | $0.06 | $-2.21 | ||
| Q1 25 | $0.05 | $-1.34 | ||
| Q4 24 | $0.05 | $-2.08 | ||
| Q3 24 | $0.05 | $-0.17 | ||
| Q2 24 | $0.12 | $0.31 | ||
| Q1 24 | $0.06 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $89.8M |
| 总债务越低越好 | $18.0M | — |
| 股东权益账面价值 | $256.5M | $194.6M |
| 总资产 | $342.7M | $289.3M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资MDXGRGP
| Q4 25 | $166.1M | $89.8M | ||
| Q3 25 | $142.1M | $77.5M | ||
| Q2 25 | $118.9M | $86.1M | ||
| Q1 25 | $106.4M | $72.5M | ||
| Q4 24 | $104.4M | $78.2M | ||
| Q3 24 | $88.8M | $89.6M | ||
| Q2 24 | $69.0M | $108.9M | ||
| Q1 24 | $48.5M | $113.8M |
总债务MDXGRGP
| Q4 25 | $18.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $19.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDXGRGP
| Q4 25 | $256.5M | $194.6M | ||
| Q3 25 | $238.9M | $206.4M | ||
| Q2 25 | $216.6M | $207.1M | ||
| Q1 25 | $202.8M | $277.8M | ||
| Q4 24 | $193.1M | $325.7M | ||
| Q3 24 | $181.0M | $407.2M | ||
| Q2 24 | $168.0M | $418.8M | ||
| Q1 24 | $155.7M | $414.9M |
总资产MDXGRGP
| Q4 25 | $342.7M | $289.3M | ||
| Q3 25 | $319.0M | $287.2M | ||
| Q2 25 | $291.1M | $304.7M | ||
| Q1 25 | $270.4M | $375.6M | ||
| Q4 24 | $263.9M | $424.9M | ||
| Q3 24 | $243.9M | $512.9M | ||
| Q2 24 | $230.2M | $510.9M | ||
| Q1 24 | $221.7M | $523.2M |
负债/权益比MDXGRGP
| Q4 25 | 0.07× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | — | $15.6M |
| 自由现金流率自由现金流/营收 | — | 13.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | $24.3M |
8季度趋势，按日历期对齐
经营现金流MDXGRGP
| Q4 25 | $25.0M | $15.9M | ||
| Q3 25 | $29.3M | $-7.8M | ||
| Q2 25 | $14.4M | $16.8M | ||
| Q1 25 | $5.3M | $659.0K | ||
| Q4 24 | $18.8M | $1.8M | ||
| Q3 24 | $19.6M | $-309.0K | ||
| Q2 24 | $21.8M | $3.2M | ||
| Q1 24 | $6.0M | $20.5M |
自由现金流MDXGRGP
| Q4 25 | — | $15.6M | ||
| Q3 25 | — | $-8.0M | ||
| Q2 25 | — | $16.5M | ||
| Q1 25 | — | $238.0K | ||
| Q4 24 | — | $61.0K | ||
| Q3 24 | — | $-575.0K | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | — | $20.4M |
自由现金流率MDXGRGP
| Q4 25 | — | 13.2% | ||
| Q3 25 | — | -6.6% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度MDXGRGP
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率MDXGRGP
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | — | ||
| Q3 24 | 2.42× | — | ||
| Q2 24 | 1.24× | 0.30× | ||
| Q1 24 | 0.65× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
